Carestream Health Inc. and Caliper Life Sciences Inc. have settled competing patent disputes, the companies said Monday. Carestream and Caliper had wrangled over patents covering in-vivo molecular imaging since last year. The process involves genetically engineered cells modified through the introduction of material such as firefly DNA or bioluminescent plant DNA to emit light. Caliper hit first in February 2010, targeting Carestream with a...